Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oxybutynin 2.5mg tablets
0704020J0AAAAAA
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 107,034 |
|
Oxybutynin 5mg tablets
0704020J0AAACAC
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 105,444 |
|
Oxybutynin 10mg modified-release tablets
0704020J0AAATAT
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 35,023 |
|
Oxybutynin 5mg modified-release tablets
0704020J0AAASAS
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 28,208 |
|
Oxybutynin 3.9mg/24hours transdermal patches
0704020J0AAAUAU
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4,832 |
|
Oxybutynin 2.5mg/5ml oral solution sugar free
0704020J0AAAFAF
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 2,709 |
|
Oxybutynin 5mg/5ml oral solution sugar free
0704020J0AAAGAG
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,828 |
|
Oxybutynin 3mg tablets
0704020J0AAABAB
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,720 |
|
Oxybutynin 2.5mg/5ml oral solution
0704020J0AAAZAZ
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 44 |
|
Oxybutynin 5mg/5ml oral liquid
0704020J0AAAMAM
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 22 |
|
Oxybutynin 2.5mg/5ml oral suspension
0704020J0AAAKAK
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | 7 |
|
Oxybutynin 12.5mg/5ml oral solution
0704020J0AAARAR
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 3mg/5ml oral solution
0704020J0AAALAL
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 3mg/5ml oral suspension
0704020J0AAAYAY
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Oxybutynin 8mg/5ml oral solution
0704020J0AAAPAP
|
Oxybutynin (Systemic) | Oxybutynin | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.